FeesSafety
Pluang+

H&R Block to announce Q1 fiscal 2027 results on Nov 9 after NYSE close

Company Fundamentals
26 Oct 2026, 23:15 WIB
GlobeNewsWire
View Source
Neutral
H&R Block to announce Q1 fiscal 2027 results on Nov 9 after NYSE close

H&R Block will release its fiscal 2027 first quarter earnings on November 9, 2026, after the New York Stock Exchange closes. The company will hold a conference call at 4:30 p.m. Eastern time the same day to discuss the results, outlook, and provide a business update. Investors and analysts can join the call via registration, and a webcast will be available for public listening and replay. This update is important as it provides insight into H&R Block's financial health and business direction amid its ongoing services in tax preparation and financial products.

H&R Block's upcoming fiscal 2027 first quarter results release is noted here with Pluang's Financials sector snapshot for context. For readers following financial stocks, as of Oct 27, 2026 02:31 WIB, 88 of 142 priced US Financials stocks on Pluang rose while 51 fell. Notable movers include GLXY at USD 15.50 (+5.59%, typical hold time 6 days), AVAT at USD 1.17 (-5.26%, 75% sell order activity, typical hold time 14 days), and FIGR at USD 22.03 (-5.00%, typical hold time 7 days).

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
2 hours ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App